Capricor Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.181; its P/E ratio is -3.62; Capricor Therapeutics is scheduled to report earnings on May 11, 2023, and the estimated EPS forecast is $-0.32. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
Income Statement	-
Total Revenue	$ 959.90K	$ 1.59M	$ 0.00	$ 0.00	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -8.07M	$ -6.48M	$ -7.32M	$ -7.83M	$ -6.38M
EBITDA	$ -7.87M	$ -6.34M	$ -7.21M	$ -7.74M	$ -6.30M
Net Income Common Stockholders	$ -7.72M	$ -6.37M	$ -7.11M	$ -7.82M	$ -6.19M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 41.42M	$ 46.61M	$ 51.42M	$ 58.33M	$ 34.89M
Total Assets	$ 50.09M	$ 53.93M	$ 58.07M	$ 64.92M	$ 41.33M
Total Debt	$ 2.56M	$ 2.78M	$ 2.74M	$ 2.80M	$ 2.87M
Net Debt	$ -38.86M	$ -43.83M	$ -48.68M	$ -55.53M	$ -32.01M
Total Liabilities	$ 38.31M	$ 38.50M	$ 39.34M	$ 40.28M	$ 9.96M
Stockholders Equity	$ 11.79M	$ 15.43M	$ 18.73M	$ 24.64M	$ 31.37M
Cash Flow	-
Free Cash Flow	$ -8.12M	$ -6.78M	$ -6.95M	$ 23.42M	$ -6.00M
Operating Cash Flow	$ -6.90M	$ -5.69M	$ -6.54M	$ 24.05M	$ -5.63M
Investing Cash Flow	$ 5.14M	$ -4.18M	$ -35.41M	$ -625.36K	$ -368.67K
Financing Cash Flow	$ 2.95M	$ 1.88M	$ 15.01K	$ 27.46K	$ 42.37K

Currency in USD

Capricor Therapeutics Earnings and Revenue History

Income Statement >

Capricor Therapeutics Debt to Assets

Balance Sheet >

Capricor Therapeutics Cash Flow

Cash Flow >

Capricor Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing